Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma

(2012) Jun Huang et al.   Autophagy

Mechanisms and management of doxorubicin cardiotoxicity

(2011) Y. Shi et al.   HERZ

Dextran–g–PEI nanoparticles as a carrier for co-delivery of adriamycin and plasmid into osteosarcoma cells

(2011) Kuo Sun et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Mechanism of anthracycline-mediated down-regulation of GATA4 in the heart

(2010) Ah-Mee Park et al.   CARDIOVASCULAR RESEARCH

Pharmacogenetics of Target Genes Across Doxorubicin Disposition Pathway: A Review

(2010) Suman Lal et al.   CURRENT DRUG METABOLISM

Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell

(2010) Min-Bin Chen et al.   JOURNAL OF CELLULAR PHYSIOLOGY

A chitosan–dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma

(2009) Hang T. Ta et al.   BIOMATERIALS

The performance of doxorubicin encapsulated in chitosan–dextran sulphate microparticles in an osteosarcoma model

(2009) Mei L. Tan et al.   BIOMATERIALS

Doxorubicin Cardiomyopathy

(2009) Kanu Chatterjee et al.   CARDIOLOGY

Doxorubicin: The Good, the Bad and the Ugly Effect

(2009) Cristina Carvalho et al.   CURRENT MEDICINAL CHEMISTRY

Chitosan-dibasic orthophosphate hydrogel: A potential drug delivery system

(2009) Hang T. Ta et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Compound K Induces Apoptosis via CAMK-IV/AMPK Pathways in HT-29 Colon Cancer Cells

(2009) Do Yeon Kim et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

ABCB8 Mediates Doxorubicin Resistance in Melanoma Cells by Protecting the Mitochondrial Genome

(2009) Aaron M. Elliott et al.   MOLECULAR CANCER RESEARCH

The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis

(2009) D. Guo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes

(2008) Jiahao Liu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

AM251 suppresses the viability of HepG2 cells through the AMPK (AMP-activated protein kinase)–JNK (c-Jun N-terminal kinase)–ATF3 (activating transcription factor 3) pathway

(2008) Yun Mi Lee et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs

(2008) Neil Ashley et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

A role for ceramide in driving cancer cell resistance to doxorubicin

(2008) Yong-Yu Liu et al.   FASEB JOURNAL

AMP-activated Protein Kinase Contributes to UV- and H2O2-induced Apoptosis in Human Skin Keratinocytes

(2008) Cong Cao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint

(2008) Dana M. Gwinn et al.   MOLECULAR CELL

Oncogenes and Cancer

(2008) Carlo M. Croce   NEW ENGLAND JOURNAL OF MEDICINE

Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide

(2008) Catherine E. Jansen et al.   PSYCHO-ONCOLOGY

Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment

(2008) Barbara Collins et al.   PSYCHO-ONCOLOGY